Samsung Bioepis Gains European Commission (EC) Approval for Denosumab Biosimilar (OBODENCE™, XBRYK™)
Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe) and XBRYK™ (120mg vial), denosumab biosimilars ...
Le Lézard7h
Samsung Bioepis Gains European Commission (EC) Approval for Denosumab Biosimilar (OBODENCEtm, XBRYKtm)
Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCEtm (60mg pre-filled syringe) and XBRYKtm (120mg vial), denosumab biosimilars ...
Hybrid training is a healthy trend, when done correctly
Thousands of social media followers are trying out the hybrid training model, but experts say the intense training style can ...
Massillon community rallies to give 7-year-old with muscular dystrophy unforgettable Valentine's Day
Residents came together to deliver thousands of cards, gifts, and thoughtful notes for one very special little boy.